Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sequent Scientific has informed that it enclosed the Investor Presentation on ‘SeQuent Scientific Limited and Viyash Lifesciences Private Limited Announce Strategic Merger to Create a Global Animal Health Leader with End-to-End Integrated Capabilities’.
The above information is a part of company’s filings submitted to BSE.